Cystosonographic measurements of canine bladder tumours

Veterinary and Comparative Oncology

Volumn 8, Issue 2, 2010, Pages 122-126

  Hume, C ^a   Seiler, G ^a   Porat Mosenco, Y ^a   Caceres, A ^a   Shofer, F ^a   Sorenmo, K ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Canine; Canine bladder tumor; Chemotherapy; Oncology; Small animal

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; BLADDER; BLADDER TUMOR; DOG; DOG DISEASE; ECHOGRAPHY; OBSERVER VARIATION; ORGAN SIZE; PATHOLOGY; STANDARD; VETERINARY MEDICINE; STANDARDS; VETERINARY; VETERINARY PATHOLOGY;

ANIMALS; DOG DISEASES; DOGS; OBSERVER VARIATION; ORGAN SIZE; PATHOLOGY, VETERINARY; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

ANIMALIA; CANIS FAMILIARIS;

EID: 77953935074     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2010.00212.x     Document Type: Article

References (10)

1. Chun R, Knapp DW, Widmer WR, DeNicola DB, Glickman NW, Kuczek T, Degortari A, Han CM. Phase II clinical trial of carboplatin in canine transitional cell carcinoma of the urinary bladder. Journal of Veterinary Internal Medicine 1997, 11:279-283.
2. Knapp DW, Glickman NW, Widmer WR, DeNicola DB, Adams LG, Kuczek T, Bonney PL, DeGortari AE, Han C, Glickman LT. Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer. Cancer Chemotherapy and Pharmacology 2000, 46:221-226.
3. Henry CJ, McCaw DL, Turnquist SE, Tyler JW, Bravo L, Sheafor S, Straw RC, Dernell WS, Madewell BR, Jorgensen L, Scott MA, Higginbotham ML, Chun R. Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma. Clinical Cancer Research 2003, 9:906-911.
4. Mohommed SI, Craig BA, Mutsaers AJ, Glickman NW, Snyder PW, deGortari AE, Sclittler DL, Coffman KT, Bonney PL, Knapp DW. Effects of the Cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Molecular Cancer Therapeutics 2003, 2:183-188.
5. Boria PA, Glickman NW, Schmidt BR, Widmer WR, Mustaers AJ, Adams LG, Snyder PW, DiBernardi L, deGortari AE, Bonney PL, Knapp DW. Carboplatin and piroxicam therapy in 31 dogs with transitional cell carcinoma of the urinary bladder. Veterinary and Comparative Oncology 2005, 3:73-80.
6. Greene SN, Lucroy MD, Greenberg CB, Bonney PL, Knapp DW. Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder. Journal of the American Veterinary Medical Association 2007, 231:1056-1060.
7. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG. New guidelines to evaluate the response to treatment in solid tumors. Journal of the National Cancer Institute 2000, 92:205-216.
8. Widmer WR, Biller DS, Adams LG. Ultrasonography of the urinary tract in small animals. Journal of the American Veterinary Association 2004, 225:46-54.
9. Nyman HT, O'Brien RT. The sonographic evaluation of lymph nodes. Clinical Techniques in Small Animal Practice 2007, 22:128-137.
10. Taeymans O, Duchateau L, Schreurs E, Kramer M, Daminet S, Sauders JH. Intra- and interobserver variability of ultrasonographic measurements of the thyroid gland in healthy beagles. Veterinary Radiology and Ultrasound 2005, 46:139-142.